Olema Pharmaceuticals (OLMA) Depreciation & Amortization (CF) (2020 - 2026)
Olema Pharmaceuticals (OLMA) has 7 years of Depreciation & Amortization (CF) data on record, last reported at $119000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 7.03% to $119000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $481000.0, a 11.09% increase, with the full-year FY2025 number at $490000.0, up 24.68% from a year prior.
- Depreciation & Amortization (CF) reached $119000.0 in Q1 2026 per OLMA's latest filing, down from $187000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for OLMA hit a ceiling of $187000.0 in Q4 2025 and a floor of $43000.0 in Q3 2025.
- A 5-year average of $102117.6 and a median of $95000.0 in 2024 define the central range for Depreciation & Amortization (CF).
- Peak YoY movement for Depreciation & Amortization (CF): surged 833.33% in 2022, then plummeted 54.74% in 2025.
- Tracing OLMA's Depreciation & Amortization (CF) over 5 years: stood at $97000.0 in 2022, then fell by 9.28% to $88000.0 in 2023, then surged by 31.82% to $116000.0 in 2024, then skyrocketed by 61.21% to $187000.0 in 2025, then tumbled by 36.36% to $119000.0 in 2026.
- Business Quant data shows Depreciation & Amortization (CF) for OLMA at $119000.0 in Q1 2026, $187000.0 in Q4 2025, and $43000.0 in Q3 2025.